Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
CA 2434544 A1 · Owner: Akpharma Inc. · Inventors: Kligerman, Alan E.; Finnegan, Sarah
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Glycerophosphates, particularly calcium glycerophosphate (CGP) have been , found to mitigate certain abdominal-area physical problems including irritable bowel syndrome and urinary urgency. It is believed that calcium and glycerophosphate, taken orally, are introduced into the human and other animal system such that the glycerophosphate and/or calcium exert a damping soothing, irritant-interdictive or antispasmodic action on the intestinal urinary bladder and other smooth muscle organs. Using glycerophosphates a , method is provided for alleviating palliating, and reducing the syndromes and conditions of discomfort resulting from a variety of diseases including , irritable bowel …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 18, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 18, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 18, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.